The largest database of trusted experimental protocols

Superscript 2 reverse transcriptase

Manufactured by Thermo Fisher Scientific
Sourced in United States, Germany, United Kingdom, France, Canada, China, Japan, Switzerland, Belgium, Australia, Netherlands, Spain, Denmark, Italy

SuperScript II Reverse Transcriptase is a reverse transcriptase enzyme used to synthesize complementary DNA (cDNA) from a single-stranded RNA template. It facilitates the conversion of RNA into cDNA, which is a crucial step in various molecular biology techniques such as gene expression analysis and cDNA library construction.

Automatically generated - may contain errors

3 887 protocols using superscript 2 reverse transcriptase

1

Quantitative Real-Time PCR Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total RNA was extracted using TRIzol reagent (Invitrogen), and complementary DNA (cDNA) templates were synthesized using SuperScript II Reverse Transcriptase (Invitrogen). Quantitative reverse transcription-PCR (qRT-PCR) and data collection were performed with an ABI PRISM 7900HT sequence detection system.
Total RNA was extracted from selected cells or tissues using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) according to the manufacturer’s instructions. Complementary DNA (cDNA) templates were synthesized using SuperScript II Reverse Transcriptase (Invitrogen). Fast Start Universal SYBR Green Master Mix (Roche Diagnostics GmbH, Mannheim, Germany) was used for qRT-PCR. The primers used to detect mRNA levels are listed in Supplementary materials.
+ Open protocol
+ Expand
2

RNA Extraction and cDNA Synthesis from Muscle Tissue

Check if the same lab product or an alternative is used in the 5 most similar protocols
The tissue was powdered with liquid nitrogen, and total RNA was extracted from 10 mg of muscle tissue using 1 mL of TRIzol® reagent (Invitrogen, Inc., USA). RNA quality was confirmed by examining 28S and 18S rRNA bands on 1.5% agarose gels stained with ethidium bromide. Total RNA was purified from all samples using an RNeasy MinElute cleanup kit (Qiagen, USA).
Complementary DNA (cDNA) synthesis was performed by reverse transcription using SuperScript™ II reverse transcriptase (Invitrogen, USA) as follows. Aliquots (4 μL) of total RNA were preincubated with 50 ng (1 μL) of random primer mix (Promega, USA) and 2.5 mM (1 μL) dNTP mix at 65°C for 5 min. The tubes were placed on ice, after which 4 μL of 5× first-stand buffer (250 mM Tris–HCl, pH 8.3, 375 mM KCl, 15 mM MgCl2), 2 μL of 0.1 M DTT, and 40 units (0.5 μL) of RNase inhibitor (Promega, USA) were added, followed by incubation at 42°C for 2 min. After addition of 200 units (1 μL) of SuperScript™ II reverse transcriptase (Invitrogen, USA), incubation was continued at 42°C for 50 min. Reverse transcriptase activity was terminated by incubation at 70°C for 15 min. The resulting cDNA was stored at −20°C until used in quantitative real-time PCR (qRT-PCR).
+ Open protocol
+ Expand
3

cDNA Synthesis from Total RNA

Check if the same lab product or an alternative is used in the 5 most similar protocols
cDNA was synthesized using 3 µg of total RNA with Super-Script II reverse transcriptase (Invitrogen, CA, USA). In 1.5 mL tubes, 3 µg total RNA from the samples and 1 µL of oligo DT (0.5 µg/µL, Invitrogen, CA, USA) were added and the final volume was brought to 12 µL with DEPC water, followed by incubation at 70℃ for 10 min [15 (link)]. A reaction buffer (4 µL 5 X first standard buffer, 2 µL 0.1 mol/L DTT, 1 µL 10 mmol/L NTP) was added to the mixture and incubated at 42℃ for 5 min. After incubation, 0.5 µL superscript II reverse transcriptase (Invitrogen, CA, USA) was added and incubated at 42℃ for 100 min, and then 70℃ for 15 min. Finally, 80 µL Rnase DEPC water was added to the mixture, which was stored at -20℃ until subsequent analysis.
+ Open protocol
+ Expand
4

Quantifying Th1, Th2, and Treg Gene Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total RNA was extracted from a sample (weighting around 70 mg) of the spleen (n = 5) using the Trizol reagent (Invitrogen, Thermo Fisher Scientific) according to the manufacturer's instructions. The total RNA from each sample was treated with DNAse I (DNAse I, Sigma-Aldrich) and was reverse transcribed into the complementary DNA (cDNA) using SuperScript™ II Reverse Transcriptase (SuperScript™ II Reverse Transcriptase, Invitrogen) according to the manufacturer's protocol. The relative mRNA levels were evaluated by quantitative RT-PCR using the StepOne™ Real-Time PCR System (Applied Biosystems, Life Technologies) and TaqMan probes® (Applied Biosystems, Life Technologies) for specific markers Th1 (TBX21), Th2 (GATA3) and Treg (FOXP3) using commercial probes (Thermo Fischer Scientific) (TBX21: Rn01461633_m1; GATA3: Rn00484683_m1 and FOXP3: Rn01525092_m1). Βeta-actin (Rn00667869_m1) was used as an endogenous control gene to normalize the amounts of RNA in the RT-PCR.
+ Open protocol
+ Expand
5

Endothelial Cell mRNA Extraction and Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total mRNA was extracted using the RNAeasy Minikit (Qiagen, Crawley, UK) according to the manufacturer’s protocol. Briefly, EC were collected from the transwell co-culture filters using accutase, lysed and then added to a column. After three washes, mRNA was eluted from the column with water. mRNA concentration was measured using NanoDrop spectrofluorimeter (LabTech) and mRNA was stored at −80 °C. To convert mRNA to cDNA, random primers (Promega, USA) were annealed to 1 μg of mRNA for 5 minutes at 70 °C, after which the following mastermix was added to give a final volume of 30 μl: 10 U Superscript II Reverse Transcriptase (RT), 10 U RNAout RNase inhibitor, 1× Superscript Buffer (all from Invitrogen) and 10 mM dNTPs (Promega). The reaction was run at 37 °C for 1 h, followed by 5 minutes at 95 °C. To analyse mRNA, FAM-labeled E-selectin and SOCS3 primers and VIC-labelled 18S primers, were bought as Assay on Demand kits from Applied Biosystems (Warrington, UK). Samples were amplified in duplicates using the 7500HT real-time PCR machine (Applied Biosystems) and analysed using the software package SDS 2.2 (Applied Biosystems). Data were expressed as relative expression units relative to 18S or as fold change (2–ΔΔCt method).
+ Open protocol
+ Expand
6

Quantifying IFN-β mRNA Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
RNA was extracted from cultured cells with TRI Reagent (Sigma–Aldrich Corporation, Lyon, France) and reverse transcribed using SuperScript II Reverse Transcriptase (RT) (Invitrogen Life Technologies) following to the manufacturer’s instructions. cDNA was subjected to PCR using PowerUp SYBR Green Master Mix (2X) (ThermoFisher Scientific) to detect IFN-β expression. The primers used for PCR detection as follows: for human IFN-β, forward primer AGCTGAAGCAGTTCCAGAAG and reverse primer AGTCTCATTCCAGCCAGTGC. Primers specific to glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (forward primer AGGGCTGCTTTTAACTCTGGT and reverse primer CCCCACTTGATTTTGGAGGGA) was served as the internal control. PCR was carried out in StepOnePlus Real-Time PCR Systems (ThermoFisher Scientific) programmed as follows: 94 °C for 15 s, 63 °C for 10 s, and 72 °C for 15 s for a total of 40 cycles, before melting curve. Results were analyzed by the ΔΔCT method, where CT is threshold cycle, and normalized to GAPDH mRNA. Data are represented as levels of mRNA relative to the mock transfected control samples and are displayed as the means ± SD of results from at least three independent experiments.
+ Open protocol
+ Expand
7

Optimized RNA Extraction and cDNA Synthesis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Snap‐frozen hearts were homogenised in TRI Reagent® (Sigma‐Aldrich), and 1‐bromo‐3‐chloro‐propane (BCP; Sigma‐Aldrich) then added. The upper aqueous phase, after centrifugation, was mixed with 2 m pH 4 sodium acetate and isopropanol. After centrifugation, the resulting pellet was dissolved in RDD buffer with DNaseI (Qiagen). Phenol : chloroform was added and the supernatant was removed, mixed with chloroform and centrifuged again. The supernatant was removed and mixed with 3 m NaAc pH 5.2 and ethanol. After centrifugation, the resulting pellet was dissolved in DEPC‐treated H2O. Purity of RNA was checked using NanoDrop 2000 (Thermo Scientific).
The cDNA synthesis was performed according to the SuperScript™ II Reverse Transcriptase (RT) (Invitrogen) protocol. RT‐positive samples had SuperScript II RT added to them, and in RT‐negative samples, SuperScript II RT was replaced with dH2O.
+ Open protocol
+ Expand
8

Quantitative PCR for IFN-β Detection

Check if the same lab product or an alternative is used in the 5 most similar protocols
RNA was extracted from hearts lysates or cultured cells with TRIzol Reagent (Invitrogen, Life Technologies) and reverse transcribed using SuperScript II Reverse Transcriptase (RT) (Invitrogen Life Technologies) following to the manufacturer’s instructions. cDNA was subjected to PCR using PowerUp SYBR Green Master Mix (2X) (ThermoFisher Scientific) to detect IFN-β. The primers used for PCR detection as follows: for mouse IFN-β, forward primer 5’- GCCTTTGCCATCCAAGAGATGC-3’ and reverse primer 5’-ACACTGTCTGCTGGTGGAGTTC-3’. Primers specific to mouse GAPDH (forward primer 5’-CATCACTGCCACCCAGAAGACTG-3’ and reverse primer 5’-ATGCCAGTGAGCTTCCCGTTCAG-3’) were used as the internal control. PCR was carried out in StepOnePlus Real-Time PCR Systems (ThermoFisher Scientific) programmed as follows: denaturation step at 94°C for 15s, annealing step at 63°C for 10s, and extension step at 72°C for 15s (40 cycles) for human primers or denaturation step at 95°C for 15s, annealing/extension step at 65°C for 1min (40 cycles) for mouse primers, before melting curve. Results were analyzed with ΔΔCT method, where CT is threshold cycle, and normalized to GAPDH mRNA. Data are represented as levels of mRNA relative to that of the mock transfected control samples and are displayed as the means ± SD of results from at least three independent in vitro experiments.
+ Open protocol
+ Expand
9

RNA Extraction and cDNA Synthesis Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
RNA was extracted from cells using an RNeasy Micro Kit (Qiagen) according to the manufacturer's instructions and converted to cDNA using Superscript II reverse-transcriptase (RT) (Invitrogen), with dNTPs and random hexamers. PCR was carried out using primers specific to NPM–ALK24 (link), RAG2 or Vα2 (OTI transgene) (OT1 FWD 5′- ACGTGTATTCCCATCTCTGG -3′, OTI R 5′- CTGTTCATAATTGGCCCGA -3′; NPM–ALK FWD 5′- TCCCTTGGGGGCTTTGAAATA -3′, NPM–ALK RVS 5′- CGAGGTGCGGAGCTTGCTCAG -3′; RAG A 5′- GGGAGGACACTCACTTGCCAGTA -3′, RAG B 5′- AGTCAGGAGTCTCCATCTCACTGA -3′ and NeoA 5′- CGGCCGGAGAACCTGCGTGCAA -3′).
+ Open protocol
+ Expand
10

Quantitative Gene Expression Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total RNA from cultured cells was extracted with RNeasy spin columns (Qiagen) or the SV Total RNA Isolation System (Promega) according to manufacturer's instructions. One μg of total RNA was reverse transcribed using oligo (dT) primers and Superscript II Reverse Transcriptase (RT) (Invitrogen, Life Technologies) following manufacturer's instructions. Conventional PCR was performed using PCR master mix (Promega). qPCR was performed using TaqMan gene expression assays (Life Technologies) according to the manufacturer's instructions. Validated TaqMan probes were selected to target specific genes as follows: SAFB1 (Hs01561652_gl), SAFB2 (Hs01006796_g1), ITGB4 (Hs00236216_m1), SHF (Hs00403125_m1), MALAT-1 (Hs00273907_s1), and β-actin (Hs99999903_m1). Data analysis was performed using the comparative Ct method normalised against β-actin expression. Experiments were performed in triplicate and statistical analysis was performed using Student's t-test or Repeated Measures ANOVA with Dunnett's Multiple Comparison Test. All effects at P < 0.05 are reported as significant.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!